The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

Blue Cross plans are retreating from GLP-1 weight-loss drug coverage after spending hundreds of millions of dollars on the ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Evernorth, the health services division of The Cigna Group (NYSE: CI) announced a first-of-its-kind pharmacy benefit offering that make weight loss medications WEGOVY® and ZEPBOUND® more ...

Healthcare & Pharmaceuticalscategory· May 22, 2025 Cigna to offer $200 Wegovy, Zepbound weight-loss benefit Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss ...

May 22, 2025 Cigna to offer $200 Wegovy, Zepbound weight-loss benefit Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.

After 72 weeks of treatment, people taking Zepbound ... for people taking Wegovy. Both drugs can provide meaningful weight loss and health improvements, but without insurance coverage, many ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.